PRRC2A and cancer: Indeed, YAP1 is overexpressed in over 80% of human CRC cases and promotes cancer progression by activating an aberrant core set of enhancers across cancers.[22] This idea is also supported by the positive correlation between CSNK1E and PRRC2A expression in CRC.